Enlarge (credit: skynesher)
Men aged 55 to 69 should talk with their doctors about the possibility of taking a blood-based prostate cancer test.

The test comes with many potential problems but brings the benefit of ever so slightly reducing the chance of dying from the cancer.

That’s according to a new draft guidance out Tuesday from the US Preventive Services Task Force, an independent panel of experts appointed by the government to make evidence-based medical recommendations.
The new guidance is a bit of a walk-back from the USPSTF’s 2012 recommendation that all men take a hard pass on the blood screening, called a PSA test. Men younger than 55 and those 70 or older are still advised to skip, according to the USPSTF.

But, the new guidance opens the door to screening on a case-by-case basis for the 55 to 69 age group.
For that group, the task force writes in its draft guidance: “the USPSTF recommends individualized decision-making about screening for prostate cancer after discussion with a clinician, so that each man has an opportunity to understand the potential benefits and harms of screening and to incorporate his values and preferences into his decision.”
Read 11 remaining paragraphs

Leave a Reply